Open AccessQuadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial
Author(s) -
Lígia A. Pinto,
Troy J. Kemp,
B. Nelson Torres,
Kimberly IsaacsSoriano,
Donna J. Ingles,
Martha Abrahamsen,
Yuanji Pan,
Eduardo LazcanoPonce,
Jorge Salmerón,
Anna R. Giuliano
Publication year - 2016
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiw359
Subject(s) - antibody , saliva , medicine , hpv vaccines , gardasil , vaccination , incidence (geometry) , virology , virus , immunoglobulin a , hpv infection , immunology , immunoglobulin g , cancer , cervical cancer , optics , physics
Human papillomavirus virus type 16 (HPV-16) and HPV-18 cause a large proportion of oropharyngeal cancers, which are increasing in incidence among males, and vaccine efficacy against oral HPV infections in men has not been previously evaluated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom